In a voluntary move, Hospira is recalling three lots of Hydromorphone HCl Injection, USP CII 10 mg/mL, 1 mL in 2 mL Single Dose Vials, lot numbers 71330DD (NDC 0409-2634-01), and 691853F and 700753F (NDC 0703-0110-01—Teva lots) to the hospital/institution level. The company initiated the recall on Feb. 7, 2018, because of the possibility that units from these lots may be empty or cracked at the bottom of the glass vial.